APA (7th ed.) Citation

M, G. P., H, M., I, K., L, V., V, H., L, V., . . . P, G. (2023). Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience. Biochemia medica, 33(3), 031201. https://doi.org/10.11613/BM.2023.031201

Chicago Style (17th ed.) Citation

M, Gomerčić Palčić, et al. "Corrigendum to: Post-treatment Neutrophil to Lymphocyte Ratio as a Prognostic Tool in Patients Treated with Tocilizumab for Severe COVID-19 Pneumonia - a Single Center Experience." Biochemia Medica 33, no. 3 (2023): 031201. https://doi.org/10.11613/BM.2023.031201.

MLA (9th ed.) Citation

M, Gomerčić Palčić, et al. "Corrigendum to: Post-treatment Neutrophil to Lymphocyte Ratio as a Prognostic Tool in Patients Treated with Tocilizumab for Severe COVID-19 Pneumonia - a Single Center Experience." Biochemia Medica, vol. 33, no. 3, 2023, p. 031201, https://doi.org/10.11613/BM.2023.031201.